BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12640118)

  • 1. HMG-I(Y) and the CBP/p300 coactivator are essential for human papillomavirus type 18 enhanceosome transcriptional activity.
    Bouallaga I; Teissier S; Yaniv M; Thierry F
    Mol Cell Biol; 2003 Apr; 23(7):2329-40. PubMed ID: 12640118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An enhanceosome containing the Jun B/Fra-2 heterodimer and the HMG-I(Y) architectural protein controls HPV 18 transcription.
    Bouallaga I; Massicard S; Yaniv M; Thierry F
    EMBO Rep; 2000 Nov; 1(5):422-7. PubMed ID: 11258482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of HMG I(Y) in the assembly and function of the IFN-beta enhanceosome.
    Yie J; Merika M; Munshi N; Chen G; Thanos D
    EMBO J; 1999 Jun; 18(11):3074-89. PubMed ID: 10357819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recruitment of CBP/p300 by the IFN beta enhanceosome is required for synergistic activation of transcription.
    Merika M; Williams AJ; Chen G; Collins T; Thanos D
    Mol Cell; 1998 Jan; 1(2):277-87. PubMed ID: 9659924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin gene transcription is mediated by interactions between the p300 coactivator and PDX-1, BETA2, and E47.
    Qiu Y; Guo M; Huang S; Stein R
    Mol Cell Biol; 2002 Jan; 22(2):412-20. PubMed ID: 11756538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetylation of HMG I(Y) by CBP turns off IFN beta expression by disrupting the enhanceosome.
    Munshi N; Merika M; Yie J; Senger K; Chen G; Thanos D
    Mol Cell; 1998 Oct; 2(4):457-67. PubMed ID: 9809067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multiprotein complex consisting of the cellular coactivator p300, AP-1/ATF, as well as NF-kappaB is responsible for the activation of the mouse major histocompatibility class I (H-2K(b)) enhancer A.
    Brockmann D; Pützer BM; Lipinski KS; Schmücker U; Esche H
    Gene Expr; 1999; 8(1):1-18. PubMed ID: 10543727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coordination of a transcriptional switch by HMGI(Y) acetylation.
    Munshi N; Agalioti T; Lomvardas S; Merika M; Chen G; Thanos D
    Science; 2001 Aug; 293(5532):1133-6. PubMed ID: 11498590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus E1A downregulates cJun- and JunB-mediated transcription by targeting their coactivator p300.
    Lee JS; See RH; Deng T; Shi Y
    Mol Cell Biol; 1996 Aug; 16(8):4312-26. PubMed ID: 8754832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The HMG-I/Y-related protein p8 binds to p300 and Pax2 trans-activation domain-interacting protein to regulate the trans-activation activity of the Pax2A and Pax2B transcription factors on the glucagon gene promoter.
    Hoffmeister A; Ropolo A; Vasseur S; Mallo GV; Bodeker H; Ritz-Laser B; Dressler GR; Vaccaro MI; Dagorn JC; Moreno S; Iovanna JL
    J Biol Chem; 2002 Jun; 277(25):22314-9. PubMed ID: 11940591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HMG I/Y regulates long-range enhancer-dependent transcription on DNA and chromatin by changes in DNA topology.
    Bagga R; Michalowski S; Sabnis R; Griffith JD; Emerson BM
    Nucleic Acids Res; 2000 Jul; 28(13):2541-50. PubMed ID: 10871404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of tumor necrosis factor alpha gene expression by mycobacteria involves the assembly of a unique enhanceosome dependent on the coactivator proteins CBP/p300.
    Barthel R; Tsytsykova AV; Barczak AK; Tsai EY; Dascher CC; Brenner MB; Goldfeld AE
    Mol Cell Biol; 2003 Jan; 23(2):526-33. PubMed ID: 12509451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus early region 3 promoter regulation by E1A/E1B is independent of alterations in DNA binding and gene activation of CREB/ATF and AP1.
    Kornuc M; Kliewer S; Garcia J; Harrich D; Li C; Gaynor R
    J Virol; 1990 May; 64(5):2004-13. PubMed ID: 2139139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FER-1, an enhancer of the ferritin H gene and a target of E1A-mediated transcriptional repression.
    Tsuji Y; Akebi N; Lam TK; Nakabeppu Y; Torti SV; Torti FM
    Mol Cell Biol; 1995 Sep; 15(9):5152-64. PubMed ID: 7651432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PU.1-mediated transcription is enhanced by HMG-I(Y)-dependent structural mechanisms.
    Lewis RT; Andreucci A; Nikolajczyk BS
    J Biol Chem; 2001 Mar; 276(12):9550-7. PubMed ID: 11124259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional regulation of the mouse ferritin H gene. Involvement of p300/CBP adaptor proteins in FER-1 enhancer activity.
    Tsuji Y; Moran E; Torti SV; Torti FM
    J Biol Chem; 1999 Mar; 274(11):7501-7. PubMed ID: 10066817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of ETS transcription factor ER81 in a complex with its coactivators CREB-binding protein and p300.
    Papoutsopoulou S; Janknecht R
    Mol Cell Biol; 2000 Oct; 20(19):7300-10. PubMed ID: 10982847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional activity of human papillomavirus type 31b enhancer is regulated through synergistic interaction of AP1 with two novel cellular factors.
    Kyo S; Tam A; Laimins LA
    Virology; 1995 Aug; 211(1):184-97. PubMed ID: 7645210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional activation of human papillomavirus 16 by nuclear factor I, AP1, steroid receptors and a possibly novel transcription factor, PVF: a model for the composition of genital papillomavirus enhancers.
    Chong T; Chan WK; Bernard HU
    Nucleic Acids Res; 1990 Feb; 18(3):465-70. PubMed ID: 2155400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo.
    Wathelet MG; Lin CH; Parekh BS; Ronco LV; Howley PM; Maniatis T
    Mol Cell; 1998 Mar; 1(4):507-18. PubMed ID: 9660935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.